Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Response After Switching in the Treatment of Migraine

NCT05785988 is registered in ClinicalTrials.gov with Hospital Clínico Universitario de Valladolid as lead sponsor.

NCT NCT05785988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05785988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Response After Switching in the Treatment of Migraine
Lead sponsor
Hospital Clínico Universitario de Valladolid
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
November 10, 2024
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head pain, migraine